Kurt H Kruger - Net Worth and Insider Trading

Kurt H Kruger Net Worth

The estimated net worth of Kurt H Kruger is at least $141 dollars as of 2024-11-13. Kurt H Kruger is the Director of Qualigen Therapeutics Inc and owns about 36 shares of Qualigen Therapeutics Inc (QLGN) stock worth over $141. Details can be seen in Kurt H Kruger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kurt H Kruger has not made any transactions after 2021-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kurt H Kruger

To

Kurt H Kruger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kurt H Kruger owns 2 companies in total, including Ritter Pharmaceuticals Inc (RTTR) , and Qualigen Therapeutics Inc (QLGN) .

Click here to see the complete history of Kurt H Kruger’s form 4 insider trades.

Insider Ownership Summary of Kurt H Kruger

Ticker Comapny Transaction Date Type of Owner
RTTR Ritter Pharmaceuticals Inc 2020-06-06 director
QLGN Qualigen Therapeutics Inc 2021-08-19 director

Kurt H Kruger Latest Holdings Summary

Kurt H Kruger currently owns a total of 1 stock. Kurt H Kruger owns 36 shares of Qualigen Therapeutics Inc (QLGN) as of August 19, 2021, with a value of $141.

Latest Holdings of Kurt H Kruger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
QLGN Qualigen Therapeutics Inc 2021-08-19 36 3.93 141

Holding Weightings of Kurt H Kruger


Kurt H Kruger Form 4 Trading Tracker

According to the SEC Form 4 filings, Kurt H Kruger has made a total of 3 transactions in Qualigen Therapeutics Inc (QLGN) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Qualigen Therapeutics Inc is the acquisition of 16 shares on August 19, 2021, which cost Kurt H Kruger around $9,840.

Insider Trading History of Kurt H Kruger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kurt H Kruger Trading Performance

GuruFocus tracks the stock performance after each of Kurt H Kruger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kurt H Kruger is -8.81%. GuruFocus also compares Kurt H Kruger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kurt H Kruger within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kurt H Kruger's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kurt H Kruger

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.75 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 10.61 LIMIT LIMIT LIMIT LIMIT LIMIT

Kurt H Kruger Ownership Network

Ownership Network List of Kurt H Kruger

No Data

Ownership Network Relation of Kurt H Kruger

Insider Network Chart

Kurt H Kruger Owned Company Details

What does Ritter Pharmaceuticals Inc do?

Who are the key executives at Ritter Pharmaceuticals Inc?

Kurt H Kruger is the director of Ritter Pharmaceuticals Inc. Other key executives at Ritter Pharmaceuticals Inc include 10 percent owner Sekisui Diagnostics, Llc , director & Chairman & President & CEO Michael S. Poirier , and Vice President of Finance & CFO Christopher L. Lotz .

Ritter Pharmaceuticals Inc (RTTR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ritter Pharmaceuticals Inc (RTTR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ritter Pharmaceuticals Inc (RTTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ritter Pharmaceuticals Inc (RTTR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ritter Pharmaceuticals Inc Insider Transactions

No Available Data

Kurt H Kruger Mailing Address

Above is the net worth, insider trading, and ownership report for Kurt H Kruger. You might contact Kurt H Kruger via mailing address: 100 Foxborough Blvd, Suite 240, Foxborough Ma 02035.